A
Market Data
$0.85−$0.27 (−23.67%)
ANEB · Last trade
Prev Close
$1.12
Range (30d)
$0.85 – $1.21
Recent Filings
- 8-K245.2 KBAnebulo Pharmaceuticals, Inc.Jan 27, 9:24 AM ET·0001493152-26-003718
- 8-K245.7 KBAnebulo Pharmaceuticals, Inc.Dec 22, 9:00 AM ET·0001493152-25-028676
- 10-Q2.9 MBAnebulo Pharmaceuticals, Inc.Nov 13, 4:31 PM ET·0001493152-25-022350
- 8-K260.1 KBAnebulo Pharmaceuticals, Inc.Nov 13, 4:15 PM ET·0001493152-25-022310
- 10-K16.0 MBAnebulo Pharmaceuticals, Inc.Sep 29, 4:31 PM ET·0001493152-25-016015
- 8-K280.0 KBAnebulo Pharmaceuticals, Inc.Sep 29, 4:15 PM ET·0001493152-25-016001
- 8-K236.3 KBAnebulo Pharmaceuticals, Inc.Sep 12, 8:00 AM ET·0001493152-25-013133
- 8-K280.7 KBAnebulo Pharmaceuticals, Inc.Jul 23, 8:16 AM ET·0001493152-25-011342
- 10-Q3.2 MBAnebulo Pharmaceuticals, Inc.May 13, 4:33 PM ET·0001641172-25-009975
- 8-K255.0 KBAnebulo Pharmaceuticals, Inc.May 13, 4:16 PM ET·0001641172-25-009952
Insiders
10- 22NW Fund, LPSee Explanation of Responses
- 22NW, LP10% Owner, See Explanation of Responses
- ALLEN SIMONChief Executive Officer
- Aryeh JasonDirector
- Calloway NathanielDirector
- Cundy Kenneth CChief Scientific Officer
- Cunningham, Richard AnthonyDirector, Chief Executive Officer
- English Aron R.Director, 10% Owner
- GARDINER SANDRA A.Acting Chief Financial Officer
- George DanChief Financial Officer
Tickers
Addresses
business
C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107
LAKEWAY, TX, 78734
mailing
C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107
LAKEWAY, TX, 78734